Literature DB >> 7660934

Dihydropyrimidinuria: the first case in Japan.

S Ohba1, K Kidouchi, S Sumi, M Imaeda, N Takeda, H Yoshizumi, A Tatematsu, K Kodama, K Yamanaka, M Kobayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7660934     DOI： 10.1007/978-1-4615-2584-4_83

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Dihydropyrimidinuria without clinical symptoms.

Authors:  S Sumi; K Kidouchi; K Hayashi; S Ohba; Y Wada
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Dihydropyrimidinase deficiency: confirmation of the enzyme defect in dihydropyrimidinuria.

Authors:  A H van Gennip; R A de Abreu; H van Lenthe; J Bakkeren; J Rotteveel; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

3.  Dihydropyrimidinase deficiency: the first feline case of dihydropyrimidinuria with clinical and molecular findings.

Authors:  Hye-Sook Chang; Takako Shibata; Satoshi Arai; Chunhua Zhang; Akira Yabuki; Sawane Mitani; Takashi Higo; Kazuhiro Sunagawa; Keijiro Mizukami; Osamu Yamato
Journal:  JIMD Rep       Date:  2012-03-29

Review 4.  Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects.

Authors:  A H van Gennip; N G Abeling; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

5.  Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity.

Authors:  Masahiro Hiratsuka; Hiroshi Yamashita; Fumika Akai; Hiroki Hosono; Eiji Hishinuma; Noriyasu Hirasawa; Takahiro Mori
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.